ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.

Katie E Hebron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.